-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
Green Bamboo Bio-LZ901 recombinant herpes zoster vaccine has obtained the approval for clinical trial, which is suitable for susceptible adults over 50 years old
After signing the license agreement with Lonza, Green Bamboo Bio can use the GS Xceed ® gene expression system to develop a scalable, stable and reliable expression process
https://pharma.
Peter Droc , Head of Licensing and Formulation Services at Lonza , said: " The entry of Green Bamboo Bio's innovative drug candidate into clinical trials marks a major step forward in the development of next-generation antibody molecules and vaccines
Mr.
Scan QR code to download GS Xceed® details: https://lonzalpb.